Skip to content
Menu
Home
Pipeline
Biology
Team
Investors
News & Events
CONTACT US
International Workshop of Scleroderma Research
July 30 – August 3, 2022
Preclinical results support the potential of APT-101 as a therapeutic for ILD, including those cases associated with SSc-ILD
Event Registration